{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["B-16 melanoma", "OV-90 ovarian carcinoma", "Ozonized oil", "ROS", "Radiation sensitivity", "\u0263H2AX"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35623299", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "20"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "11"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "05", "Day": "13"}], "ELocationID": ["10.1016/j.bbrc.2022.05.030", "S0006-291X(22)00728-8"], "Journal": {"ISSN": "1090-2104", "JournalIssue": {"Volume": "615", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "30"}}, "Title": "Biochemical and biophysical research communications", "ISOAbbreviation": "Biochem Biophys Res Commun"}, "ArticleTitle": "Ionizing radiation induced DNA damage via ROS production in nano ozonized oil treated B-16 melanoma and OV-90 ovarian cells.", "Pagination": {"StartPage": "143", "EndPage": "149", "MedlinePgn": "143-149"}, "Abstract": {"AbstractText": ["In this study, we aimed to investigate ozonized oil nanoemulsions (OZNEs) as a radiosensitizer within B-16 melanoma and OV-90 ovarian cells under X-ray irradiation in\u00a0vitro. Radiation sensitivity of OZNE treated B-16 melanoma cells and OV-90 ovarian cells were evaluated by performing cell cycle analysis, Reactive Oxygen Species (ROS) and \u0263-H2AX assays by flow cytometry. OZNEs induced G0-1 phase arrest of B-16 melanoma cells for all radiation doses and G2/M arrest for 8\u00a0Gy and 15\u00a0Gy doses. OZNE treated B-16 melanoma and OV-90 ovarian cells induced DNA damage via the increase in ROS production, as well as significant increase in the expression of \u0263-H2AX under even low doses of radiation (2\u00a0Gy). Thus, OZNEs are suggested to help to optimize cancer RT as a radiosensitizer and further studies will significantly outperform recent advances in this field."], "CopyrightInformation": "Copyright \u00a9 2022 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nanotechnology Engineering, Zonguldak B\u00fclent Ecevit University, Incivez, Zonguldak, 67100, Turkey."}], "LastName": "Yal\u00e7\u0131n", "ForeName": "Yeliz", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Zonguldak B\u00fclent Ecevit University, School of Medicine, Zonguldak, 67100, Turkey."}], "LastName": "Tekin", "ForeName": "\u0130shak \u00d6zel", "Initials": "\u0130\u00d6"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nanotechnology Engineering, Zonguldak B\u00fclent Ecevit University, Incivez, Zonguldak, 67100, Turkey; Department of Biomedical Engineering, Zonguldak B\u00fclent Ecevit University, Incivez, Zonguldak, 67100, Turkey. Electronic address: rseda.tigli@gmail.com."}], "LastName": "T\u0131\u011fl\u0131 Ayd\u0131n", "ForeName": "R Seda", "Initials": "RS"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biochem Biophys Res Commun", "NlmUniqueID": "0372516", "ISSNLinking": "0006-291X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Radiation-Sensitizing Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "DNA Damage"}, {"QualifierName": [], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Melanoma"}, {"QualifierName": [], "DescriptorName": "Radiation, Ionizing"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Radiation-Sensitizing Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "4", "Day": "19"}, {"Year": "2022", "Month": "5", "Day": "3"}, {"Year": "2022", "Month": "5", "Day": "10"}, {"Year": "2022", "Month": "5", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "27", "Hour": "18", "Minute": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35623299", "10.1016/j.bbrc.2022.05.030", "S0006-291X(22)00728-8"]}}], "PubmedBookArticle": []}